| # | Title | Journal | Year | Citations |
|---|
| 1 | Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 1,430 |
| 2 | Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 564 |
| 3 | Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 481 |
| 4 | Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 450 |
| 5 | [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 431 |
| 6 | Nitroimidazoles and imaging hypoxia | European Journal of Nuclear Medicine and Molecular Imaging | 1995 | 354 |
| 7 | FDG-PET for clinical use | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 338 |
| 8 | Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus | European Journal of Nuclear Medicine and Molecular Imaging | 1991 | 279 |
| 9 | Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 278 |
| 10 | FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 272 |
| 11 | Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 267 |
| 12 | Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck | European Journal of Nuclear Medicine and Molecular Imaging | 1999 | 261 |
| 13 | The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 230 |
| 14 | Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate | European Journal of Nuclear Medicine and Molecular Imaging | 1986 | 228 |
| 15 | Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 225 |
| 16 | 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 225 |
| 17 | Advantage of delayed whole-body FDG-PET imaging for tumour detection | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 221 |
| 18 | Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography | European Journal of Nuclear Medicine and Molecular Imaging | 1994 | 213 |
| 19 | First experience in healthy volunteers with technetium-99m l,l-ethylenedicysteine, a new renal imaging agent | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 206 |
| 20 | Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 206 |
| 21 | Experience with carbon-11 choline positron emission tomography in prostate carcinoma | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 206 |
| 22 | Imaging of dopamine transporters in humans with technetium-99m TRODAT 1 | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 201 |
| 23 | Recent progress in fluorine-18 labelled peptide radiopharmaceuticals | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 198 |
| 24 | Labelling and metabolism of methionine-methyl-11C | European Journal of Nuclear Medicine and Molecular Imaging | 1976 | 196 |
| 25 | Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 196 |
| 26 | Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 193 |
| 27 | Radiopharmaceuticals in sentinel lymph-node detection – an overview | European Journal of Nuclear Medicine and Molecular Imaging | 1999 | 192 |
| 28 | Bayesian image reconstruction for emission tomography based on median root prior | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 187 |
| 29 | Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 186 |
| 30 | Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 182 |
| 31 | A radiopharmaceuticals schedule for imaging in paediatrics | European Journal of Nuclear Medicine and Molecular Imaging | 1990 | 173 |
| 32 | Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 165 |
| 33 | Radiation synovectomy revisited | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 160 |
| 34 | DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 160 |
| 35 | Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography in patients with coronary artery disease | European Journal of Nuclear Medicine and Molecular Imaging | 1992 | 159 |
| 36 | Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 159 |
| 37 | 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 158 |
| 38 | Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 156 |
| 39 | Imaging infection/inflammation in the new millennium | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 156 |
| 40 | A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime | European Journal of Nuclear Medicine and Molecular Imaging | 1995 | 151 |
| 41 | In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 150 |
| 42 | A prototype high-resolution animal positron tomograph with avalanche photodiode arrays and LSO crystals | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 150 |
| 43 | Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours | European Journal of Nuclear Medicine and Molecular Imaging | 1994 | 149 |
| 44 | Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 149 |
| 45 | Somatostatin analogue scintigraphy in carcinoid tumours | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 148 |
| 46 | New radioiodinated methyl-branched fatty acids for cardiac studies | European Journal of Nuclear Medicine and Molecular Imaging | 1986 | 146 |
| 47 | Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 146 |
| 48 | The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma | European Journal of Nuclear Medicine and Molecular Imaging | 1995 | 145 |
| 49 | Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 144 |
| 50 | Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi | European Journal of Nuclear Medicine and Molecular Imaging | 1994 | 141 |
